Friday 6 November 2026
Export TFX’s income statement to Excel — free account
Teleflex Incorporated
TFX Healthcare Medical Instruments & Supplies
Teleflex Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 17.2% from fiscal 2024.
- Revenue
- +0.15%
- EPS
- +342.0%
- Free cash flow
- +220.1%
- Total debt
- −39.4%
Quarter to September 2026, against a year earlier
151.46
0.69
−0.45%
Follow TFX
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 7 |
| (24.47%) | (28.10%) | (28.87%) | 0.00% | ||
| (12.90%) | (14.47%) | (14.57%) | 4.28% | ||
ROIC |
1.37% | 0.73% | 0.51% | 7.46% | |
Return on Tangible Assets |
(54.08%) | (62.71%) | (63.25%) | 21.79% | |
Average Days of Receivables |
63.30 | 62.73 | 59.03 | 61.44 | |
Free Cash Flow per Share |
0.03 | 4.03 | 1.22 | 3.44 | |
Free Cash Flow |
1.45 | 178.56 | 53.12 | 142.73 | |
Capital Expenditures |
(95.24) | (89.89) | (76.14) | (55.09) | |
| Other line items | |||||
Cash ROIC |
0.02% | 2.97% | 0.88% | 2.57% | |
Accounts Receivable Turnover |
6.96 | 5.12 | 5.13 | 4.64 | |
Accounts Payable Turnover |
7.65 | 6.66 | 6.75 | 4.88 | |
Inventory Turnover |
2.45 | 1.86 | 1.94 | 1.27 | |
Average Days of Payables |
54.50 | 54.95 | 51.48 | 69.21 | |
Days of Inventory on Hand |
169.28 | 145.72 | 126.44 | 186.21 | |
Tax Rate |
1.38 | (1.04) | (0.61) | (0.04) | |
Research and Development Expense of Revenue |
7.27% | 7.71% | 8.10% | 7.46% | |
Selling, General and Administrative Expense of Revenue |
36.14% | 37.30% | 38.56% | 35.84% | |
Share Based Compensation of Revenue |
1.29% | 1.21% | 1.14% | 0.95% | |
Interest Coverage |
1.18 | 0.58 | 0.39 | 5.42 | |
Operating CF/Net income |
(0.11) | (0.27) | (0.13) | 0.65 | |
Depreciation/Fixed assets |
0.37 | 0.42 | 0.45 | (0.59) | |
Capex/Depreciation |
(0.52) | (0.45) | (0.36) | 0.20 | |
Revenue per Share |
44.66 | 48.05 | 51.75 | 54.37 | |
Operating CF per Share |
2.17 | 6.07 | 2.97 | 4.77 | |
Capex per Share |
(2.13) | (2.03) | (1.75) | (1.33) | |
Capex to Sales |
0.05 | 0.04 | 0.03 | 0.02 |
Columns are period end dates · fundamentals updated 6 Nov 2026